TrialCancer research communications2022

Affordable Prices Without Threatening the Oncological R&D Pipeline-An Economic Experiment on Transparency in Price Negotiations.

Nora Franzen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.